Research on Traditional Chinese Medicine (TCM) Clinical Treatment of the Acute Episode of Bronchial Asthma.
NCT ID: NCT01293734
Last Updated: 2011-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
360 participants
INTERVENTIONAL
2008-12-31
2011-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study on the Treatment of Bronchial Asthma With Traditional Chinese Medicine
NCT02937207
REspiratory diSEAse cohoRt Studies of CHinese Medicine for Asthma (RESEARCH- Asthma)
NCT06373692
Effects of Traditional Chinese Medicine on Bronchiectasis Patients
NCT03443531
Study on the Correlation Between TCM Syndrome, Inflammatory Phenotype and Biomarker of Bronchial Asthma
NCT04128111
Effectiveness of Chinese Herbal Therapy for Asthma
NCT00712296
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
cold type
To comply with the diagnostic standard of bronchial asthma in western medicine and TCM syndrome in cold type
warming lung and relieving asthmatic granule and Securing origin and warming lung emplastrum
warming lung and relieving asthmatic granule:once 1 bag, 3 times a day. Securing origin and warming lung emplastrum: paste on acupuncture point and take the emplastrum down after 3 hours, once a day
heat type
To comply with the diagnostic standard of bronchial asthma in western medicine and TCM syndrome in heat type.
clearing lung and relieving asthmatic granule and securing origin and clearing lung emplastrum
clearing lung and relieving asthmatic granule: once 1 bag, 3 times a day. securing origin and clearing lung emplastrum: paste on acupuncture point and take the emplastrum down after 3 hours, once a day
Asthenia type
To comply with the diagnostic standard of bronchial asthma in western medicine and TCM syndrome in Asthenia type.
securing origin and relieving asthmatic granule and securing origin and nourishing lung emplastrum
securing origin and relieving asthmatic granule: once 1 bag, 3 times a day. securing origin and nourishing lung emplastrum: paste on acupuncture point and take the emplastrum down after 3 hours, once a day
Western medicine control group
Theophylline Sustained-release Tablets and budesonide suspension
Theophylline Sustained-release Tablets 0.2g a time, twice a day. budesonide suspension for inhalation 100ug, twice a day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
warming lung and relieving asthmatic granule and Securing origin and warming lung emplastrum
warming lung and relieving asthmatic granule:once 1 bag, 3 times a day. Securing origin and warming lung emplastrum: paste on acupuncture point and take the emplastrum down after 3 hours, once a day
clearing lung and relieving asthmatic granule and securing origin and clearing lung emplastrum
clearing lung and relieving asthmatic granule: once 1 bag, 3 times a day. securing origin and clearing lung emplastrum: paste on acupuncture point and take the emplastrum down after 3 hours, once a day
securing origin and relieving asthmatic granule and securing origin and nourishing lung emplastrum
securing origin and relieving asthmatic granule: once 1 bag, 3 times a day. securing origin and nourishing lung emplastrum: paste on acupuncture point and take the emplastrum down after 3 hours, once a day
Theophylline Sustained-release Tablets and budesonide suspension
Theophylline Sustained-release Tablets 0.2g a time, twice a day. budesonide suspension for inhalation 100ug, twice a day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with mild-to-moderate bronchial asthma on attacking stage;
* Without cardiopulmonary or other complications;
* To comply with the diagnostic standard of bronchial asthma in western medicine and TCM syndrome differentiation;
* Informed consent form is required to be signed.
Exclusion Criteria
* Pregnant woman or suckling period woman;
* Patients combine serious primary disease in liver, renal, cardiovascular and cerebrovascular, hemopoietic system diseases,or psychosis.
* Severe levels of disease is between severe and critical extent. Combine Pulmonary Heart Disease or respiratory failure;
* Irritable the physique, or allergic to the given composition of drugs in this research;
* Patients who are in the process of other clinical research.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shenyang Huanggu District Central Hospital
UNKNOWN
Benxi City hospital of Chinese medicine
OTHER
Anshan Central Hospital
OTHER
Liaoning University of Traditional Chinese Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
No.2 Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
sygzwu
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.